Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice
CRISPR/Cas9 technology has been used for genome engineering in vivo. Here, the authors use a transfection technique to deliver multiple guide RNAs to the pancreas of adult mice, allowing genetic screening and chromosome engineering in pancreatic cancer.
Main Authors: | Roman Maresch, Sebastian Mueller, Christian Veltkamp, Rupert Öllinger, Mathias Friedrich, Irina Heid, Katja Steiger, Julia Weber, Thomas Engleitner, Maxim Barenboim, Sabine Klein, Sandra Louzada, Ruby Banerjee, Alexander Strong, Teresa Stauber, Nina Gross, Ulf Geumann, Sebastian Lange, Marc Ringelhan, Ignacio Varela, Kristian Unger, Fengtang Yang, Roland M. Schmid, George S. Vassiliou, Rickmer Braren, Günter Schneider, Mathias Heikenwalder, Allan Bradley, Dieter Saur, Roland Rad |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2016-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms10770 |
Similar Items
-
Correlation of in vivo imaging to morphomolecular pathology in translational research: challenge accepted
by: Simone Ballke, et al.
Published: (2021-08-01) -
Autoimmune Pancreatitis Type 1 Associated with a Pancreatic Pseudocyst
by: Felix Hesse, et al.
Published: (2019-04-01) -
Neuroinflammation after intracerebral hemorrhage
by: Eva eMracsko, et al.
Published: (2014-11-01) -
Polymerisationseigenschaften des Synaptonemalkomplexproteins SYCP1 und Charakterisierung von Bindungspartnern : Architektur meiotischer Chromosomen
by: Öllinger, Rupert
Published: (2005) -
Arterial Pseudoaneurysm within a Pancreatic Pseudocyst
by: Veit Phillip, et al.
Published: (2018-08-01)